ReviewFrontiers in immunology2026

Research progress in augmentation strategies for PD-1/PD-L1 inhibitors in bladder cancer: from biological determinants to clinical applications.

Yaxin Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.